跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 100 条关于
“ESCMID”
全部
100
临床试验
61
药物
16
机构
1
资讯
22
去年
Theriva Biologics Presents Phase 1b/2a Safety Data for SYN-004 in Hematopoietic Cell Transplant Recipients at ESCMID Global
去年
BioVersys Reports Strong Survival Benefit in Phase 2 Trial of BV100 for Carbapenem-Resistant Acinetobacter Infections
去年
Longhorn Vaccines Advances Universal Flu Vaccine with Broad Cross-Species Protection
去年
Enanta Pharmaceuticals to Present Promising RSV Antiviral Data at Major European Medical Conferences
5个月前
Shionogi's Cefiderocol Shows 68% Clinical Cure Rate Against Highly Resistant MBL-Producing Enterobacterales in Real-World Study
去年
Zoliflodacin Shows Promise Against Resistant Gonorrhea in Phase 3 Trial
5个月前
HIV Treatment Reverses Accelerated Biological Aging by Nearly Four Years, Swiss Study Reveals
4个月前
F2G's Olorofim Shows Promise in High-Risk Hematology Patients with Invasive Aspergillosis
3个月前
Bruker Unveils Expanded MALDI Biotyper Library and Rapid Sepsis AST Workflow at ASM Microbe 2026
5个月前
Model Medicines Secures First US Patent for AI-Discovered Broad-Spectrum Antiviral MDL-001
第 1 页,共 3 页
上一页
下一页